Originally posted on Mets Merized Online  |  Last updated 2/10/13
In his first interview since being denied first ballot entry into the Hall of Fame, Mike Piazza spoke candidly with David Waldstein of the New York Times ahead of the release of his autobiography, Long Shot, due out on February 11. In the book, Piazza admits to using androstenedione as part of a supplement pack until the outcry over Mark McGwire’s use of it forced him to phase it out. He flatly denies ever using steroids. “It shouldn’t be assumed that every big hitter of the generation used steroids,” Piazza says. Naturally, Piazza was disappointed that he wasn’t elected to the Hall of Fame this year. “I won’t deny there is some disappointment, but I understand it’s a process.” If Yogi Berra and Joe DiMaggio did not make it on their first ballots, Piazza says he is in no position to complain. “I don’t have an ax to grind, I don’t have a bone to pick with people,” he told Waldstein, “I wrote this book because I had a very interesting life and a very interesting career. I wanted to
GET THE YARDBARKER APP:
Ios_download En_app_rgb_wo_45
MORE FROM YARDBARKER

Sanu: Halftime show played role in Super Bowl collapse

James Dolan is among potential group of investors of new arena for New York Islanders

Report: Rams, Clippers discussing NBA venue in Inglewood

Terrence Jones reportedly interested in joining Celtics

LeBron reverses course, says he ‘always felt good’ about Cavs

LIKE WHAT YOU SEE?
GET THE DAILY NEWSLETTER:

Report: Ole Miss tried to implicate Mississippi State in football scandal

Jamaal Charles could be on the roster bubble

Jimmy Butler on state of Bulls: ‘I just want to win at all costs’

Report: Giants will be ‘aggressive’ in trying to sign Jason Pierre-Paul

Report: Porzingis avoided ligament damage in ankle

Brooks Koepka meltdown includes whiff, stomping head off driver

Top 10 shortstops in baseball for 2017

The most dangerous NBA teams flying under the radar

Eat, Drink, Watch: Your award-worthy weekend planning guide

Grading the NBA trade deadline on the Vince Carter scale

Box Score 2/24: A night of NBA disrespect

As NHL trade deadline nears, seven teams who could be dealing

The 'Pete Rose instead of Kareem? Surely, you can't be serious' quiz

Streaming sports docuseries you don't want to miss

Teams that can prevent a Cavs-Warriors NBA Finals three-peat

The NFL off-season is a passer’s fancy

The Aesthetic: Pushing the boundaries of the three-pointer

NBA coaches who should be fired soon

MLB News
Delivered to your inbox
You'll also receive Yardbarker's daily Top 10, featuring the best sports stories from around the web. Customize your newsletter to get articles on your favorite sports and teams. And the best part? It's free!

By clicking "Sign Me Up", you have read and agreed to the Fox Sports Digital Privacy Policy and Terms of Use. You can opt out at any time. For more information, please see our Privacy Policy.
the YARDBARKER app
Get it now!
Ios_download En_app_rgb_wo_45

James Dolan is among potential group of investors of new arena for New York Islanders

Top 10 shortstops in baseball for 2017

The most dangerous NBA teams flying under the radar

Eat, Drink, Watch: Your award-worthy weekend planning guide

Grading the NBA trade deadline on the Vince Carter scale

Streaming sports docuseries you don't want to miss

As NHL trade deadline nears, seven teams who could be dealing

The 'Pete Rose instead of Kareem? Surely, you can't be serious' quiz

Teams that can prevent a Cavs-Warriors NBA Finals three-peat

The NFL off-season is a passer’s fancy

Today's Best Stuff
For Publishers
Company Info
Help
Follow Yardbarker